IMNM vs REGN: Which Stock is Better?
Side-by-side comparison of Immunome Inc and Regeneron Pharmaceuticals Inc in 2026
IMNM
Immunome Inc
$22.90
REGN
Regeneron Pharmaceuticals Inc
$755.51
Key Metrics Comparison
| Metric | IMNM | REGN | Winner |
|---|---|---|---|
| Market Cap | $2.56B | $78.92B | REGN |
| P/E Ratio | N/A | 17.99 | REGN |
| EPS (TTM) | $N/A | $41.50 | REGN |
| Revenue Growth | -1.0% | 0.0% | REGN |
| Gross Margin | -2454.2% | 44.6% | REGN |
Analyze IMNM
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMNM or REGN a better investment?
Comparing IMNM and REGN: Immunome Inc has a market cap of $2.56B while Regeneron Pharmaceuticals Inc has $78.92B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMNM and REGN?
IMNM (Immunome Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMNM or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMNM or REGN?
REGN has higher revenue growth at 0.0% vs -1.0% for IMNM.
Which company is more profitable: IMNM or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to -2454.2% for IMNM.
Which is the larger company: IMNM or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.92B compared to $2.56B for IMNM.
Should I buy IMNM or REGN in 2026?
Both IMNM and REGN have investment merit. IMNM trades at $22.90 while REGN trades at $755.51. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMNM and REGN stock?
Key differences: Market Cap ($2.56B vs $78.92B), P/E Ratio (N/A vs 18.0x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (-2454.2% vs 44.6%).